Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice. - Wikidata - awgldk - TriplyDB

Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice.

Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice.

http://www.wikidata.org/entity/Q39400640

about

Adjuvant Therapy of Uveal Melanoma: Current Status A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations.Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.Combination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cells Decitabine: a promising epi-immunotherapeutic agent in solid tumors.Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Improving cancer immunotherapy with DNA methyltransferase inhibitors.Moringa oleifera fruit induce apoptosis via reactive oxygen species-dependent activation of mitogen-activated protein kinases in human melanoma A2058 cells.DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning.Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice.Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects

P2860

Q26865325-D8640981-4D1D-4FA3-9F58-13AB24F768F2 Q33415592-2722E32F-16BF-443D-BA1E-8601378A2738 Q35788935-D6A54180-DC05-4045-9E08-4318F8F74969 Q37285301-8BE239DF-F805-4CF9-B05E-5472225564CE Q38314204-D5EF9AE3-FA5C-4E48-90E8-CF66A958FE76 Q38447992-6E35E16B-482C-4B73-BDD6-560FA730C1E2 Q38662760-6E550293-5117-4853-A799-18F40A3B6487 Q41142797-EF382133-3478-480D-8D32-582319AF4D9F Q41247038-02A1C7B2-CD44-4ED8-97AC-A12B00A60243 Q42549680-3BE33330-02F8-4A01-A225-636687D9079F Q47595821-A485A948-FCD9-4F5B-8EF3-9188818623D9 Q57138927-5423C21D-8720-4073-B436-020462355EDB

P2860

Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice.

http://www.wikidata.org/entity/Q39400640

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Differential effects of low-do ...... nses in melanoma-bearing mice.

@en

Differential effects of low-do ...... nses in melanoma-bearing mice.

@nl

type

label

Differential effects of low-do ...... nses in melanoma-bearing mice.

@en

Differential effects of low-do ...... nses in melanoma-bearing mice.

@nl

prefLabel

Differential effects of low-do ...... nses in melanoma-bearing mice.

@en

Differential effects of low-do ...... nses in melanoma-bearing mice.

@nl

P1433

Q39400640-ACFAC76E-3479-4407-AAB1-ACD4B08F1E12

P1476

Q39400640-ECE1FE70-2DD4-4B13-9647-F5D244504CE7

P2093

Q39400640-68FB1EBE-9CB7-4AB5-A34C-561825336BBB

Q39400640-7CBB58C8-8307-49DA-9641-42405434CB12

Q39400640-C997D1D0-9C39-41C4-A89D-C393E9D50EAF

Q39400640-D1CB4330-5F80-4F29-B016-A1D91B9C93CE

Q39400640-F2CE3B78-504F-4DB2-8724-8ED1808E1C16

Q39400640-F883CF5E-EFCF-42CE-80F3-78CDBD3CDF15

P2860

Q39400640-00FD257A-5A7B-41BA-A1C7-49B7275E0484

Q39400640-0587C8AD-11E3-43FE-92C5-9DC9580D3F2E

Q39400640-08DBFD92-5F63-4E77-B371-37FA26B6B1B1

Q39400640-14467FC1-6DA7-4838-B81F-0305547D88D2

Q39400640-2180648B-7309-4586-9154-33C6F2057968

Q39400640-3786B48A-6013-4CA4-AFCA-10C6F9C47F09

Q39400640-3C8F1160-02DC-4EB2-8454-4C6F117F9C98

Q39400640-450BD069-E78B-4479-AFA4-93DD6597E599

Q39400640-46CF7C32-212A-4E0D-B01B-2F8D20AB7560

Q39400640-5441D87B-363F-4C98-A374-D89C714CDF2E

P2888

Q39400640-50DB0C45-20CD-4A76-BE69-7D48AB9835BD

P304

Q39400640-611A8AF9-C9C9-42DC-961E-C97F5F78E1C2

P31

Q39400640-3CFA592A-132D-463A-8E47-99776E6EC524

P356

Q39400640-01DEE59E-CF0B-41EF-A895-BD555EFB6349

P433

Q39400640-0997EA1B-4DF7-40CF-85C5-B34872D23A69

P478

Q39400640-6DA2343F-C2CF-42C8-9A4F-62AE9A3AFD70

P577

Q39400640-A0E6F310-3A69-4DD9-9B30-8E8BF5BE108C

P698

Q39400640-31F1D95C-50B9-45D6-A9D0-EDCBD0B79B7C

P356

S00262-012-1204-X

P1433

Cancer Immunology, Immunotherapy

P1476

Differential effects of low-do ...... nses in melanoma-bearing mice.

@en

P2093

Oscar Alcazar

http://www.w3.org/2001/XMLSchema#string

Pierre L Triozzi

http://www.w3.org/2001/XMLSchema#string

Selvarangan Ponnazhagan

http://www.w3.org/2001/XMLSchema#string

Susan Achberger

http://www.w3.org/2001/XMLSchema#string

Wayne Aldrich

http://www.w3.org/2001/XMLSchema#string

Yogen Saunthararajah

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer: back to Virchow?

Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells

Use of epigenetic modification to induce FOXP3 expression in naïve T cells

Toll-like receptor control of the adaptive immune responses

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency

In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production.

CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

P2888

s00262-012-1204-x

P304

1441-1450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-012-1204-X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22310929

http://www.w3.org/2001/XMLSchema#string